Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruben Smith

Showing results (71-80 of 139) with videos related to

Pageof 14
Sort By:
Acta Neuropathologica|September 19, 2024
Association of in vivo retention of [<sup>18</sup>f] flortaucipir pet with tau neuropathology in corresponding brain regionsTove Freiburghaus, Daria Pawlik, Kevin Oliveira Hauer, et al.
Brain : a Journal of Neurology|September 9, 2022
Phospho-tau with subthreshold tau-PET predicts increased tau accumulation rates in amyloid-positive individualsColin Groot, Ruben Smith, Erik Stomrud, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 14, 2022
Tau-PET is superior to phospho-tau when predicting cognitive decline in symptomatic AD patientsRuben Smith, Nicholas C Cullen, Alexa Pichet Binette, et al.
Human Molecular Genetics|September 22, 2006
Cholinergic neuronal defect without cell loss in Huntington's diseaseRuben Smith, Hinfan Chung, Sara Rundquist, et al.
EMBO Molecular Medicine|July 13, 2021
Tau PET correlates with different Alzheimer's disease-related features compared to CSF and plasma p-tau biomarkersRik Ossenkoppele, Juhan Reimand, Ruben Smith, et al.
Brain : a Journal of Neurology|March 16, 2021
Early stages of tau pathology and its associations with functional connectivity, atrophy and memoryDavid Berron, Jacob W Vogel, Philip S Insel, et al.
Annals of Neurology|October 14, 2023
Combined Connectomics, MAPT Gene Expression, and Amyloid Deposition to Explain Regional Tau Deposition in Alzheimer DiseaseLukai Zheng, Anna Rubinski, Jannis Denecke, et al.
JAMA Neurology|May 8, 2023
Comparison of Group-Level and Individualized Brain Regions for Measuring Change in Longitudinal Tau Positron Emission Tomography in Alzheimer DiseaseAntoine Leuzy, Alexa Pichet Binette, Jacob W Vogel, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersLyduine E Collij, Gemma Salvadó, Kanta Horie, et al.
Nature Communications|April 9, 2026
Trajectories of plasma and CSF MTBR-tau243 and phosphorylated-tau species across the Alzheimer's disease continuumLyduine E Collij, Gemma Salvadó, Kanta Horie, et al.
Pageof 14

Showing results (71-80 of 139) with videos related to

Sort By:
Pageof 14
Acta Neuropathologica|September 19, 2024
Association of in vivo retention of [<sup>18</sup>f] flortaucipir pet with tau neuropathology in corresponding brain regionsTove Freiburghaus, Daria Pawlik, Kevin Oliveira Hauer, et al.
Brain : a Journal of Neurology|September 9, 2022
Phospho-tau with subthreshold tau-PET predicts increased tau accumulation rates in amyloid-positive individualsColin Groot, Ruben Smith, Erik Stomrud, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 14, 2022
Tau-PET is superior to phospho-tau when predicting cognitive decline in symptomatic AD patientsRuben Smith, Nicholas C Cullen, Alexa Pichet Binette, et al.
Human Molecular Genetics|September 22, 2006
Cholinergic neuronal defect without cell loss in Huntington's diseaseRuben Smith, Hinfan Chung, Sara Rundquist, et al.
EMBO Molecular Medicine|July 13, 2021
Tau PET correlates with different Alzheimer's disease-related features compared to CSF and plasma p-tau biomarkersRik Ossenkoppele, Juhan Reimand, Ruben Smith, et al.
Brain : a Journal of Neurology|March 16, 2021
Early stages of tau pathology and its associations with functional connectivity, atrophy and memoryDavid Berron, Jacob W Vogel, Philip S Insel, et al.
Annals of Neurology|October 14, 2023
Combined Connectomics, MAPT Gene Expression, and Amyloid Deposition to Explain Regional Tau Deposition in Alzheimer DiseaseLukai Zheng, Anna Rubinski, Jannis Denecke, et al.
JAMA Neurology|May 8, 2023
Comparison of Group-Level and Individualized Brain Regions for Measuring Change in Longitudinal Tau Positron Emission Tomography in Alzheimer DiseaseAntoine Leuzy, Alexa Pichet Binette, Jacob W Vogel, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersLyduine E Collij, Gemma Salvadó, Kanta Horie, et al.
Nature Communications|April 9, 2026
Trajectories of plasma and CSF MTBR-tau243 and phosphorylated-tau species across the Alzheimer's disease continuumLyduine E Collij, Gemma Salvadó, Kanta Horie, et al.
Pageof 14